Clinical Trial

The Clinical Role of Anogenital Distance

Study acronym: AGD
Completed
View on ClinicalTrials.gov →
Summary
Aims: To evaluate the predictive value of anogenital distance (AGD) measurements, including the anus-to-clitoris distance (AGDAC) and genital hiatus (GH), on the success of pelvic floor muscle training (PFMT) in women with stress urinary incontinence (SUI). Methods: This cross-sectional, case-control study included 150 adult women with clinically confirmed stress urinary incontinence who completed a three-month PFMT program. All patients' demographic data were recorded, and the anogenital distance (AGDAC, AGDAF) and genital hiatus (GH) were measured using a digital caliper in the lithotomy position. All participants performed supervised Kegel exercises three times daily with monthly follow-up to ensure proper technique and compliance. Patients were then classified as responders or non-responders based on clinical improvement. Associations between PFMT outcomes and AGD parameters, BMI, parity, and other demographic factors were analyzed. All patients will be assessed using the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) before and after treatment.
Trial Details
NCT Number NCT07363174
Lead Sponsor Cigdem Cinar
Conditions Pelvic Floor Muscle Exercise
Enrollment 150 participants
Start Date 2023-12-23
Primary Completion 2024-03-23 (estimated)
Study Completion 2024-06-23 (estimated)
Updated on ClinicalTrials.gov 2026-01-23